Results 251 to 260 of about 1,001,999 (283)
Some of the next articles are maybe not open access.
Current status of contraceptive vaginal rings
Contraception, 2013Contraceptive vaginal rings (CVR) offer a new, effective contraceptive option, expanding the available choices of hormonal contraception. Various ring prototypes have been evaluated: progestin-only rings and combined progestin-estrogen rings, as well as different combination of progestins and estrogens.
Vivian, Brache +2 more
openaire +2 more sources
Management of the neglected vaginal ring pessary
International Urogynecology Journal, 2006We present two cases of vaginal pessaries left in situ for prolonged periods and subsequent impaction that were managed differently. One was partially epithelialized and removed in the outpatient clinic by a new technique whereby the ring pessary was divided by a bone-cutter and passed through the epithelial tunnel without anesthesia. The second, which
Ruwan J, Fernando +3 more
openaire +2 more sources
Vaginal yeast adherence to the combined contraceptive vaginal ring (CCVR)
Contraception, 2007The purpose of this study was to evaluate the in vitro adherence of different yeasts, isolated from vaginal exudates of patients with vulvovaginal candidiasis (VVC), to the combined contraceptive vaginal ring--NuvaRing.Four isolates of Candida sp. and one isolate of Saccharomyces cerevisiae were used.
Daiane Pereira, Camacho +5 more
openaire +2 more sources
Effects of contraceptive vaginal ring treatment on vaginal bacteriology and cytology
Contraception, 1983The presence of aerobic and anaerobic bacteria, yeasts and mycoplasma/ureaplasma was investigated in seventeen women before and after six months use of a contraceptive vaginal ring releasing levo-Norgestrel and estradiol and in 16 women using an oral contraceptive containing levo-Norgestrel and ethinylestradiol. Apart from an increase in yeasts in both
A, Schwan, T, Ahrén, A, Victor
openaire +2 more sources
The effect of a contraceptive vaginal ring and oral contraceptives on the vaginal flora
Contraception, 1981Premenopausal women seeking a steroid contraceptive method were allowed to choose between a contraceptive vaginal ring (CVR) containing levonorgestrel and estradiol used in a 3-week in, 1-week out regimen (n=20) and an oral contraceptive (OC) containing levonorgestrel and ethinyl estradiol in a 28-day regimen (n = 10).
S, Roy, J, Wilkins, D R, Mishell
openaire +2 more sources
Contraception, 2000
Little is known about the effects of contraceptive vaginal rings on the vaginal surface epithelium, although most studies have not demonstrated any significant deleterious effect. However, one study found that some medium-to-long-term levonorgestrel-releasing ring users developed chronic erythematous and ulcerative lesions in the posterior vaginal ...
E, Weisberg +8 more
openaire +2 more sources
Little is known about the effects of contraceptive vaginal rings on the vaginal surface epithelium, although most studies have not demonstrated any significant deleterious effect. However, one study found that some medium-to-long-term levonorgestrel-releasing ring users developed chronic erythematous and ulcerative lesions in the posterior vaginal ...
E, Weisberg +8 more
openaire +2 more sources
Vaginal Rings for Menopausal Symptom Relief
Drugs & Aging, 2004The vagina is an alternative delivery site of sex steroids for menopausal women. New ring technology provides continuous and consistent delivery of steroids for up to 3 months. Rings rest on the pelvic floor muscles in a nearly horizontal position and are usually imperceptible.
openaire +2 more sources
Update on contraceptive vaginal rings
Reviews in Gynaecological Practice, 2003Abstract Since the development of the combined oral contraceptive pill (OCP) four decades ago, women have been able to plan their childbearing more effectively than before. Studies of women’s attitudes, however, show that many regard the compliance required with daily pill use as a drawback to the use of the oral contraception and would prefer a ...
openaire +1 more source
Vaginal Rings for Contraceptive Use
1999Steroids released from vaginal rings avoid first pass hepatic metabolism, producing high bio-availability. It has long been recognised that drug absorption occurs across the vaginal mucosa (Macht, 1918). The first vaginal ring study was that described by Mishell et al, 1970.
openaire +1 more source

